MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 50.02M | 50.04M | 55.13M | 59.25M | 61.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.02M | 50.04M | 55.13M | 59.25M | 61.33M |
| Cost of Revenue | 46.83M | 44.67M | 44.43M | 43.56M | 42.84M |
| Gross Profit | 3.19M | 5.37M | 10.70M | 15.69M | 18.49M |
| SG&A Expenses | 14.86M | 14.29M | 14.54M | 15.29M | 16.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.69M | 58.96M | 58.97M | 58.85M | 58.84M |
| Operating Income | -11.67M | -8.91M | -3.84M | 398.00K | 2.49M |
| Income Before Tax | -19.27M | -12.88M | -3.31M | 1.29M | 3.30M |
| Income Tax Expenses | -9.00K | -9.00K | -44.00K | -56.00K | -41.00K |
| Earnings from Continuing Operations | -19.26 | -12.87 | -3.27 | 1.34 | 3.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.26M | -12.87M | -3.27M | 1.34M | 3.34M |
| EBIT | -11.67M | -8.91M | -3.84M | 398.00K | 2.49M |
| EBITDA | -11.38M | -8.58M | -3.50M | 764.00K | 2.90M |
| EPS Basic | -0.57 | -0.38 | -0.10 | 0.04 | 0.10 |
| Normalized Basic EPS | -0.38 | -0.26 | -0.09 | -0.01 | 0.03 |
| EPS Diluted | -0.58 | -0.39 | -0.10 | 0.03 | 0.09 |
| Normalized Diluted EPS | -0.38 | -0.26 | -0.09 | -0.01 | 0.03 |
| Average Basic Shares Outstanding | 134.21M | 133.94M | 132.90M | 132.53M | 131.90M |
| Average Diluted Shares Outstanding | 134.21M | 146.31M | 145.28M | 160.99M | 160.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
